Cite
HARVARD Citation
Callahan, M. et al. (n.d.). Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab. Journal for immunotherapy of cancer. p. . [Online].